Skip to main content
. 2019 Feb 11;23(3):369–382. doi: 10.1007/s40291-019-00387-0

Table 5.

Loss of heterozygosity/microsatellite instability frequency (%) in studied chromosomal regions within individual pathological groups

Pathological features LOH/MSI frequency (%) in chromosomal region
1p31.2 3p21.3 3p24.2 9p21.3 11p15.5 16q22.1
Histopathological type
 NG 7 7 14 17 17 13
 FA 20 11 40a 25 20 20
 PTC 11 16a 0 0 6 7
 FTC 29a 33a 0 25 25 0
pTNM
 T1a + T1b 4 20a 0 0 0 4
 T2–T3 44a 14 0 18 33a 9
 N0 + Nx 7 18a 0 8 6 4
 N1 38a 20 0 0 25a 13
AJCC
 I 12 20a 0 4 7 8
 II–IV 22a 14 0 11 18a 0
Td (mm)
  < 10 6 20a 0 11 0 0
 10–30 25a 15 0 6 11 11
  > 30 18 13 25 10 33a 22

AJCC American Joint Committee on Cancer stage, FA follicular adenoma, FTC follicular thyroid carcinoma, LOH loss of heterozygosity, MSI microsatellite instability, N0/Nx no regional lymph node involvement, N1 regional lymph node involvement, NG nodular goiter, PTC papillary thyroid carcinoma, pTNM pathological tumor-node-metastasis, T1 tumor size pT1, T2T3 tumor size pT2–T3, Td tumor diameter

aComparison between particular chromosomal regions within an individual pathological group P < 0.05